hepat
c
viru
hcv
infect
approxim
million
person
worldwid
despit
reduct
last
two
decad
becom
major
public
health
issu
liver
injuri
induc
viru
thought
mainli
immun
mediat
rather
result
direct
cytopath
effect
infect
estim
approxim
hcvinfect
individu
elimin
viru
spontan
wherea
develop
mild
form
diseas
progress
chronic
form
fibrosi
princip
complic
chronic
hepat
c
increas
morbid
mortal
complic
cirrhosi
hepatocarcinoma
innat
respons
hcv
slow
viral
replic
activ
cytokin
trigger
synthesi
antivir
protein
wherea
adapt
immun
system
neutral
viru
particl
destroy
infect
cell
complement
protein
involv
earli
innat
respons
pathogen
play
role
clear
circul
viral
antigen
blood
infect
host
mannanbind
lectin
mbl
collectin
encod
gene
act
directli
opsonin
activ
mblassoci
serin
proteas
masp
initi
antibodyindepend
pathway
complement
activ
three
masp
describ
play
predomin
function
role
activ
lectin
pathway
wherea
form
complex
pattern
recognit
molecul
mbl
ficolin
hficolin
lficolin
mficolin
activ
one
protein
recogn
microorgan
lead
subsequ
cleavag
thu
initi
complement
cascad
activ
hcv
encod
two
highli
glycosyl
envelop
protein
potenti
target
interact
mbl
ficolin
encod
gene
chromosom
mrna
encod
exon
singl
exon
encod
linker
region
serin
proteas
domain
protein
compos
six
modul
linker
region
ntermin
cub
domain
follow
epiderm
growth
factor
egf
like
domain
ca
bind
type
second
cub
domain
contigu
complement
control
protein
modul
short
linker
final
chymotrypsinlik
serin
proteas
sp
domain
interact
mbl
lficolin
determin
ntermin
moieti
strengthen
presenc
modul
two
complement
control
protein
ccp
molecul
sp
domain
perform
catalyt
activ
entir
molecul
retain
essenti
role
cleavag
mbl
defici
occur
frequenc
common
congenit
immunodefici
associ
suscept
infect
autoimmun
disord
inherit
defici
describ
result
mutat
caus
exchang
aspart
acid
glycin
posit
first
domain
involv
calcium
bind
mutat
prohibit
bind
mbl
ficolin
depriv
function
activ
frequenc
gene
mutat
among
caucasian
individu
sever
natur
occur
polymorph
gene
describ
differ
popul
nine
singl
nucleotid
polymorph
snp
observ
p
p
thiel
et
al
report
reduct
level
individu
mutat
recent
group
observ
present
protein
misfold
therefor
unabl
associ
mbl
mutant
haplotyp
link
diseas
progress
respons
therapi
hcv
infect
howev
impact
polymorph
suscept
hcv
infect
yet
address
although
mechan
respons
develop
sever
hcv
diseas
patient
understood
like
viral
well
host
immun
factor
play
import
role
process
present
studi
examin
sever
function
polymorph
brazilian
patient
moder
sever
chronic
hepat
c
defin
low
high
fibrosi
stage
score
use
primer
set
amplifi
region
encod
first
domain
fifth
domain
gene
total
patient
men
women
studi
mean
standard
deviat
age
year
citi
curitiba
southern
brazil
supplementari
tabl
inform
consent
obtain
particip
studi
approv
institut
review
board
particip
center
patient
posit
antihcv
atibodi
enzymelink
immunosorb
assay
elisa
posit
viral
rna
use
revers
transcriptionpolymeras
chain
reaction
amplicor
hcv
version
roch
branchburg
nj
patient
year
age
stage
higher
liver
fibrosi
accord
metavir
classif
includ
exclus
criteria
follow
alcohol
use
g
g
daili
women
men
respect
coinfect
hepat
b
viru
human
immunodefici
viru
hiv
presenc
liver
system
diseas
patient
treat
convent
pgifn
associ
ribavirin
genotyp
determin
previous
use
realtim
polymeras
chain
reaction
fluoresc
hybrid
probe
gender
ethnic
agematch
control
group
compos
healthi
individu
supplementari
tabl
concentr
patient
estim
timeresolv
immunofluorometr
assay
trifma
trifma
sandwichtyp
method
use
combin
two
monoclon
antibodi
quantifi
serum
serum
dilut
appli
allow
detect
ng
g
serum
exon
gene
encod
map
analyz
use
polymeras
chain
reaction
pcr
primer
set
amplifi
part
region
encod
first
domain
amplifi
part
region
encod
fifth
domain
complement
control
protein
domain
exon
respect
cub
domain
critic
format
function
complex
domain
essenti
cleavag
cycl
condit
follow
denatur
templat
dna
one
cycl
second
amplif
target
dna
cycl
second
second
second
pcr
follow
mutat
screen
via
singl
strand
conform
polymorph
sscp
previous
describ
abnorm
band
pattern
detect
sscp
analysi
direct
dna
sequenc
carri
confirm
allel
genotyp
allel
frequenc
obtain
direct
count
allel
frequenc
distribut
patient
control
popul
compar
fisher
exact
test
possibl
associ
genotyp
allel
suscept
sever
diseas
analyz
test
fisher
exact
test
statistica
parametr
student
test
use
quantit
data
level
genotyp
compar
group
use
anova
least
signific
differ
test
level
signific
set
p
linkag
disequilibrium
measur
r
valu
use
haploview
softwar
rang
r
linkag
disequilibrium
consid
marker
pair
r
regard
silico
analys
aminoacid
sequenc
isoform
use
work
obtain
uniprotkbswissprot
version
silico
function
analysi
snp
perform
program
polyphen
predict
function
effect
human
nssnp
http
genet
bwhharvardedupph
main
databas
use
program
includ
human
snp
dbsnp
build
protein
quaternari
structur
pq
protein
data
bank
pdb
dictionari
secondari
structur
protein
dssp
structur
databas
identifi
five
snp
patient
control
group
g
g
c
g
c
tabl
allel
genotyp
frequenc
consist
expect
accord
hardyweinberg
equilibrium
linkag
disequilibrium
detect
among
five
polymorph
r
gene
frequenc
variant
occur
accord
previou
report
caucasian
popul
addit
silico
analys
snp
indic
g
predict
caus
damag
protein
variant
show
profil
score
amino
acid
substitut
psic
evolutionari
preserv
residu
seen
correspond
posit
differ
speci
tabl
evolutionari
preserv
also
observ
variat
conserv
seen
three
four
group
speci
analyz
howev
profil
score
variat
repres
harm
effect
tabl
upon
comparison
genotyp
frequenc
patient
control
variant
g
reach
statist
signific
genotyp
gg
significantli
increas
suscept
hcv
infect
p
odd
ratio
confid
interv
ci
low
frequenc
polymorph
level
compar
c
signific
associ
concentr
observ
presenc
allel
rang
ngml
domin
model
g
test
level
significantli
higher
gg
gt
genotyp
hcv
patient
p
fig
analysi
respons
ifn
ribavirin
treatment
posit
c
show
eight
patient
posit
c
nonrespond
statist
signific
observ
two
group
p
p
respect
associ
found
genotyp
variant
c
degre
liver
fibrosi
p
p
respect
studi
investig
function
polymorph
eurobrazilian
patient
moder
sever
chronic
hepat
c
import
molecul
activ
complement
system
via
mbl
ficolin
demonstr
variant
g
associ
hcv
infect
recent
studi
report
mutat
associ
low
level
function
defici
caucasian
individu
individu
homozyg
mutat
abil
activ
mbl
pathway
thiel
et
al
previous
describ
presenc
variant
result
misfold
protein
unabl
associ
mbl
subsequ
activ
contrast
result
show
variant
g
associ
suscept
hcv
infect
consid
domin
function
allel
variant
associ
high
plasma
level
hepat
c
patient
although
complement
cascad
activ
presenc
variant
g
analyz
present
studi
specul
individu
homozyg
polymorph
may
less
function
possibl
amino
acid
chang
posit
caus
modif
catalyt
region
enzym
alter
substrat
specif
although
convers
aspart
acid
tyrosin
g
accommod
molecul
without
disturb
overal
structur
possibl
variat
function
effect
respons
hcv
infect
thiel
et
al
report
allel
c
influenc
level
differ
among
homozyg
individu
signific
boldt
et
al
report
variant
associ
vari
plasma
level
chronic
chaga
diseas
nevertheless
signific
associ
allel
genotyp
suscept
sever
greater
score
indic
higher
probabl
impair
protein
function
factor
taken
account
calcul
score
follow
differ
thermophys
properti
wt
mutant
protein
evolutionari
preserv
residu
correspond
posit
acut
respiratori
syndrom
sar
coronaviru
infect
observ
beij
guangzhou
popul
multivari
analysi
includ
ifn
respons
liver
fibrosi
reveal
associ
level
polymorph
studi
result
suggest
per
se
play
immunomodulatori
role
treatment
ifn
ribavirin
shown
mbl
bind
glycoprotein
hcv
particl
activ
result
neutral
viru
nonfunct
complement
cascad
interrupt
contribut
viral
persist
sever
studi
indic
associ
hepat
c
alv
pedroso
et
al
studi
gene
polymorph
promot
region
exon
patient
chronic
diseas
report
genotyp
xa
xa
xayo
yoyo
associ
lower
level
mbl
patient
polymorph
may
therefor
associ
develop
chronic
hepat
c
halla
et
al
investig
gene
brazilian
hcv
patient
suggest
hyo
haplotyp
could
associ
hcv
infect
liver
fibrosi
present
studi
analyz
previou
data
group
follow
genotyp
observ
patient
homozyg
g
allel
variant
lypblxpa
lyqahypa
hypdlypa
hypahypa
investig
necessari
relat
effect
gene
polymorph
specif
genotyp
hcv
patient
conclus
polymorph
particularli
variant
may
increas
risk
develop
chronic
hepat
c
data
suggest
genet
factor
addit
environment
factor
import
develop
progress
hcv
infect
result
howev
replic
differ
popul
confirm
genet
influenc
snp
hepat
c
